Measurement of primary haemostasis using a pressure clamp technique

Platelets

Volumn 12, Issue 8, 2001, Pages 462-470

  Kretschmer, V ^a   Bade, S ^a   Weippert Kretschmer, M ^a   Kratzer, M A A ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; BLOOD VOLUME; BONE MARROW HYPOPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEMATOCRIT; HEMODYNAMICS; HEMOSTASIS; HUMAN; MALE; NON INVASIVE MEASUREMENT; PRESSURE CLAMP TECHNIQUE; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA;

EID: 0035668295     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100120093965     Document Type: Article

References (27)

1. Simulation of primary haemostasis in vitro
2. Detection of abnormal platelet function with an in vitro model of primary haemostasis
3. Evaluation of an in vitro bleeding time device, Thrombostat 4000
4. Advances in methods for platelet function analysis
5. In vitro bleeding test - A simple method for the detection of aspirin effects on platelet function
6. Clinical implications of the in vitro bleeding test - A review
7. Standardization of the PFA-100® platelet function test in 105 mmol/l buffered citrate: Effect of gender, smoking and oral contraceptives
8. Evaluation of platelet function by PFA-100™
9. Platelet function analyzer (PFA-100™) in the screening of type I von Willebrand disease
10. The platelet function analyzer (PFA-100™): A novel in-vitro system for evaluation of primary haemostasis in children
11. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease
12. PFA-100™ system: A new method for assessment of platelet dysfunction
13. Performance of the platelet function analyzer (PFA-100™) in clinical practice
14. Therapeutic monitoring of von Willebrand disease: Interest and limits of a platelet function analyser at high shear rates
15. Performance of the platelet function analyzer PFA-100™ in testing abnormalities of primary haemostasis
16. Determination and treatment of disorders of primary haemostasis - Experience with routine application of the in vitro bleeding test
17. A comparison of the effects of aspirin on bleeding time measured using the Simplate™ method and closure time measured using the PFA-100™, in healthy volunteers
18. PFA-100™ system: A sensitive screening test for platelet-related haemostasis defects
19. PFA-100™ provides a rapid screening test to identify children with severe bleeding disorders
20. Easy testing of platelet function in children by means of the PFA-100™
21. Platelet function analyzer (PFA-100™) for screening of von Willebrand disease (vWD)
22. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man
23. The standardized normal Ivy bleeding time and its prolongation by aspirin
24. Thrombocytopenia-adapted in vitro bleeding test assesses platelet function in thrombocytopenic patients
25. Determination of bleeding risk in thrombocytopenic patients receiving platelet substitution
26. A contribution to the indications for platelet transfusion and determination of its therapeutic efficacy